150 related articles for article (PubMed ID: 23670965)
1. Sample size and power for a logrank test and Cox proportional hazards model with multiple groups and strata, or a quantitative covariate with multiple strata.
Lachin JM
Stat Med; 2013 Nov; 32(25):4413-25. PubMed ID: 23670965
[TBL] [Abstract][Full Text] [Related]
2. Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated.
Royston P; Parmar MK
BMC Med Res Methodol; 2016 Feb; 16():16. PubMed ID: 26869168
[TBL] [Abstract][Full Text] [Related]
3. Sample size calculation for the augmented logrank test in randomized clinical trials.
Hattori S; Komukai S; Friede T
Stat Med; 2022 Jun; 41(14):2627-2644. PubMed ID: 35319100
[TBL] [Abstract][Full Text] [Related]
4. A simulation study comparing the power of nine tests of the treatment effect in randomized controlled trials with a time-to-event outcome.
Royston P; B Parmar MK
Trials; 2020 Apr; 21(1):315. PubMed ID: 32252820
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous treatment effects in stratified clinical trials with time-to-event endpoints.
Beisel C; Benner A; Kunz C; Kopp-Schneider A
Biom J; 2017 May; 59(3):511-530. PubMed ID: 28263395
[TBL] [Abstract][Full Text] [Related]
6. Sample size evaluation for a multiply matched case-control study using the score test from a conditional logistic (discrete Cox PH) regression model.
Lachin JM
Stat Med; 2008 Jun; 27(14):2509-23. PubMed ID: 17886235
[TBL] [Abstract][Full Text] [Related]
7. Hazard ratio inference in stratified clinical trials with time-to-event endpoints and limited sample size.
Xu R; Mehrotra DV; Shaw PA
Pharm Stat; 2019 May; 18(3):366-376. PubMed ID: 30706642
[TBL] [Abstract][Full Text] [Related]
8. Using the geometric average hazard ratio in sample size calculation for time-to-event data with composite endpoints.
Cortés Martínez J; Geskus RB; Kim K; Melis GG
BMC Med Res Methodol; 2021 May; 21(1):99. PubMed ID: 33957892
[TBL] [Abstract][Full Text] [Related]
9. Sample size determination for comparing several survival curves with unequal allocations.
Halabi S; Singh B
Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
[TBL] [Abstract][Full Text] [Related]
10. Comparing sample size formulae for trials with unbalanced allocation using the logrank test.
Hsieh FY
Stat Med; 1992 Jun; 11(8):1091-8. PubMed ID: 1496196
[TBL] [Abstract][Full Text] [Related]
11. Combined test versus logrank/Cox test in 50 randomised trials.
Royston P; Choodari-Oskooei B; Parmar MKB; Rogers JK
Trials; 2019 Mar; 20(1):172. PubMed ID: 30885277
[TBL] [Abstract][Full Text] [Related]
12. A clinical trial design using the concept of proportional time using the generalized gamma ratio distribution.
Phadnis MA; Wetmore JB; Mayo MS
Stat Med; 2017 Nov; 36(26):4121-4140. PubMed ID: 28815655
[TBL] [Abstract][Full Text] [Related]
13. Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates.
Hsieh FY; Lavori PW
Control Clin Trials; 2000 Dec; 21(6):552-60. PubMed ID: 11146149
[TBL] [Abstract][Full Text] [Related]
14. An approach to trial design and analysis in the era of non-proportional hazards of the treatment effect.
Royston P; Parmar MK
Trials; 2014 Aug; 15():314. PubMed ID: 25098243
[TBL] [Abstract][Full Text] [Related]
15. Power of logrank test and Cox regression model in clinical trials with heterogeneous samples.
Akazawa K; Nakamura T; Palesch Y
Stat Med; 1997 Mar; 16(5):583-97. PubMed ID: 9089965
[TBL] [Abstract][Full Text] [Related]
16. Smoothing spline-based score tests for proportional hazards models.
Lin J; Zhang D; Davidian M
Biometrics; 2006 Sep; 62(3):803-12. PubMed ID: 16984323
[TBL] [Abstract][Full Text] [Related]
17. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
[TBL] [Abstract][Full Text] [Related]
18. Sample size determination for comparing more than two survival distributions.
Ahnn S; Anderson SJ
Stat Med; 1995 Oct; 14(20):2273-82. PubMed ID: 8552903
[TBL] [Abstract][Full Text] [Related]
19. Application of the Wei-Lachin multivariate one-directional test to multiple event-time outcomes.
Lachin JM; Bebu I
Clin Trials; 2015 Dec; 12(6):627-33. PubMed ID: 26336199
[TBL] [Abstract][Full Text] [Related]
20. The impact of covariate imbalance on the size of the logrank test in randomized clinical trials.
Kinukawa N; Nakamura T; Akazawa K; Nose Y
Stat Med; 2000 Aug; 19(15):1955-67. PubMed ID: 10900445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
